Citation Impact
Citing Papers
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
2013
ARID1A , a Factor That Promotes Formation of SWI/SNF-Mediated Chromatin Remodeling, Is a Tumor Suppressor in Gynecologic Cancers
2011
Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube
2016
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
2010 StandoutScience
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Human Epidermal Growth Factor Receptor 2 Assessment in a Case-Control Study: Comparison of Fluorescence In Situ Hybridization and Quantitative Reverse Transcription Polymerase Chain Reaction Performed by Central Laboratories
2010
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study
2009
Phase II Study of Weekly Docetaxel and Trastuzumab for Patients With HER-2–Overexpressing Metastatic Breast Cancer
2002
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition
2014
Triple-Negative Breast Cancer
2010 Standout
High-resolution mapping of copy-number alterations with massively parallel sequencing
2008
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
QuPath: Open source software for digital pathology image analysis
2017 Standout
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ
2011
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
2012 Standout
Breast cancer
2016 Standout
Utility of p16 Expression for Distinction of Uterine Serous Carcinomas From Endometrial Endometrioid and Endocervical Adenocarcinomas
2009
Endometrial Carcinomas
2011
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
Epidemiology and survival outcomes of mucinous adenocarcinomas: A SEER population-based study
2018
Ovarian cancer
2014 Standout
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Cancer Metastasis: Building a Framework
2006 Standout
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Microenvironmental regulation of cancer development
2008
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Relationship Between Clinical and Pathologic Features of Ductal Carcinoma In Situ and Patient Age
2009
Adhesion in Mammary Development
2015
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer Syndrome
2006
Breast Cancer Metastasis
2013
Non-viral vectors for gene-based therapy
2014 Standout
The regulation of E2F by pRB-family proteins
1998 Standout
A Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer
2015
miRNA–target chimeras reveal miRNA 3′-end pairing as a major determinant of Argonaute target specificity
2015 StandoutNobel
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Integrated genomic characterization of endometrial carcinoma
2013 StandoutNature
Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status
2010
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Resident memory T cells, critical components in tumor immunology
2018
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
The association between endometriosis and ovarian cancer: A review of histological, genetic and molecular alterations
2011
Emerging Biological Principles of Metastasis
2017 Standout
In vivo serial diffusion tensor imaging of experimental spinal cord injury
2006
EMT: 2016
2016 Standout
Alternative lengthening of telomeres: models, mechanisms and implications
2010
Targeting metastasis
2016
TGFβ in Cancer
2008 Standout
Intraoperative detection and removal of microscopic residual sarcoma using wide‐field imaging
2012 StandoutNobel
Development of an Unsupervised Pixel-based Clustering Algorithm for Compartmentalization of Immunohistochemical Expression Using Automated QUantitative Analysis
2009
The expression of miR-30a* and miR-30e* is associated with a dualistic model for grading ovarian papillary serious carcinoma
2014
Traumatic spinal cord injury
2017 Standout
The role of senescent cells in ageing
2014 StandoutNature
The meaning of p16ink4aexpression in tumors
2011
Recent progress in the diagnosis and treatment of ovarian cancer
2011
Endometriosis: pathogenesis and treatment
2013 Standout
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
2010
Tumour evolution inferred by single-cell sequencing
2011 StandoutNature
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data
2012
Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses
2012
Molecular characterization of the tumor microenvironment in breast cancer
2004
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Regulation of In Situ to Invasive Breast Carcinoma Transition
2008
Longitudinal Comparison of Two Severities of Unilateral Cervical Spinal Cord Injury Using Magnetic Resonance Imaging in Rats
2008
Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase
2018 StandoutNobel
Caenorhabditis elegans ALG-1 antimorphic mutations uncover functions for Argonaute in microRNA guide strand selection and passenger strand disposal
2015 StandoutNobel
Hereditary gynaecological malignancies: advances in screening and treatment
2012
Diverse Regulation of SNF2h Chromatin Remodeling by Noncatalytic Subunits
2008
Ovarian Cancer
2008
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
Basal-Like Breast Cancer: A Critical Review
2008
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential
2013
The Biology of Chromatin Remodeling Complexes
2009 Standout
Endometriosis
2020 Standout
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
2011 Standout
Cancer Genome Landscapes
2013 StandoutScience
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Enhancing Surgical Vision by Using Real-Time Imaging of αvβ3-Integrin Targeted Near-Infrared Fluorescent Agent
2011
The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancer
2014
Gene therapy clinical trials worldwide to 2012 – an update
2013
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Isolation and characterization of a chicken homolog of the E2F-1 transcription factor.
1995
The Molecular Balancing Act of p16INK4a in Cancer and Aging
2013
Works of Russell Vang being referenced
Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy
2017
Immunohistochemical Determination of HER-2/neu Expression in Invasive Breast Carcinoma
2000
A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers
2003
The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression
2009
Endogenous recovery of injured spinal cord: Longitudinal in vivo magnetic resonance imaging
2004
A binary histologic grading system for ovarian serous carcinoma is an independent prognostic factor: A population-based study of 4317 women diagnosed in Denmark 1978–2006
2012
Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis
2011
Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion
2003
Validation of an Algorithm for the Diagnosis of Serous Tubal Intraepithelial Carcinoma
2012
Defining the Cut Point Between Low-grade and High-grade Ovarian Serous Carcinomas
2009
TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high‐grade serous carcinoma—evidence supporting the clonal relationship of the two lesions
2011
Endocervical Adenocarcinomas With Ovarian Metastases
2008
Endometrial Carcinoma and Non-Hodgkin's Lymphoma Involving the Female Genital Tract: A Report of Three Cases
2000
Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases
2005
Perivascular Epithelioid Cell Tumor (`PEComa') of the Uterus
2002
Separate Cavity Margin Sampling at the Time of Initial Breast Lumpectomy Significantly Reduces the Need for Reexcisions
2005
Papillary Tubal Hyperplasia
2011
Estrogen Receptor α and Progesterone Receptor Expression in Ovarian Adult Granulosa Cell Tumors and Sertoli-Leydig Cell Tumors
2007
Immunohistochemical Staining for Ki-67 and p53 Helps Distinguish Endometrial Arias-Stella Reaction from High-Grade Carcinoma, Including Clear Cell Carcinoma
2004
MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors
2011
Borderline ovarian tumors: Diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images1 1This report contains statements that include a variety of suggestions and recommendations. In view of the wide range of opinions regarding the tumors under discussion, none of these statements is intended as, or should be interpreted as, representing the “standard of care.”
2004
Nuclear size distinguishes low- from high-grade ovarian serous carcinoma and predicts outcome
2005
Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma
2006
Diagnosis of Serous Tubal Intraepithelial Carcinoma Based on Morphologic and Immunohistochemical Features
2011
Ovarian Low-grade and High-grade Serous Carcinoma
2009
Coexisting High-grade Vulvar Intraepithelial Neoplasia (VIN) and Condyloma Acuminatum
2012
Most Basal-like Breast Carcinomas Demonstrate the Same Rb−/p16+ Immunophenotype as the HPV-related Poorly Differentiated Squamous Cell Carcinomas Which They Resemble Morphologically
2009
Endocervical Adenocarcinomas With Prominent Endometrial or Endomyometrial Involvement Simulating Primary Endometrial Carcinomas
2009
Subdividing Ovarian and Peritoneal Serous Carcinoma Into Moderately Differentiated and Poorly Differentiated Does not Have Biologic Validity Based on Molecular Genetic and In Vitro Drug Resistance Data
2008
Immunohistochemical Analysis of Clear Cell Carcinoma of the Gynecologic Tract
2001
Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma
2005
Origin and Pathogenesis of Pelvic (Ovarian, Tubal, and Primary Peritoneal) Serous Carcinoma
2013
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
2009
Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?
2010